Marco Rubatto

14PUBLICATIONS
43CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Environmental epidemiologyMedical mycologyNanomedicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Sep 02, 2026
Cemiplimab in cutaneous squamous cell carcinoma: a longer follow-up study focusing on the late toxicities.

|Feb 26, 2025
Effectiveness of Brodalumab for the Treatment of Moderate-to-Severe Psoriasis: A Retrospective, Real-World Multicenter Study with a Focus on Obese and Multi-Failure Patients-IL PSO (Italian Landscape Psoriasis).

Diego Orsini, Dario Graceffa, Martina Burlando

|May 25, 2024
Eosinophilic Dermatosis of Hematologic Malignancy: Emerging Evidence for the Role of Insect Bites-A Retrospective Clinico-Pathological Study of 35 Cases.

Andrea Michelerio, Marco Rubatto, Gabriele Roccuzzo

|Jun 19, 2023
BRAFV600 variant allele frequency predicts outcome in metastatic melanoma patients treated with BRAF and MEK inhibitors.

Mario Mandalà, Giuseppe Palmieri, Vienna Ludovini

|Jan 21, 2023
Sentinel Lymph Node Biopsy in Malignant Melanoma of the Head and Neck: A Single Center Experience.

Marco Rubatto, Franco Picciotto, Giovenale Moirano

|Dec 11, 2022
The Analysis of Trends in Survival for Patients with Melanoma Brain Metastases with Introduction of Novel Therapeutic Options before the Era of Combined Immunotherapy-Multicenter Italian-Polish Report.

Joanna Placzke, Paweł Teterycz, Pietro Quaglino

Pageof 3

Frequent Collaborators

7 joint publications

Simone Ribero

4 joint publications

Pietro Quaglino

3 joint publications

Gianluca Avallone

3 joint publications

Luca Mastorino